Romosozumab: A Novel Injectable Sclerostin Inhibitor With Anabolic and Antiresorptive Effects for Osteoporosis.

Kimberly L. Nealy,Kira B. Harris

Romosozumab: A Novel Injectable Sclerostin Inhibitor With Anabolic and Antiresorptive Effects for Osteoporosis.

2020

Kimberly L. Nealy
Kira B. Harris

Objective:To review the clinical pharmacology, efficacy, and safety of romosozumab, a humanized monoclonal antibody with a novel mechanism of action for monthly injection, and its place in the mana...

Keywords:

Romosozumab
Medicine
Mechanism of action
Monoclonal antibody
Osteoporosis
Sclerostin
Anabolism
Clinical pharmacology
Pharmacology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations